The discovery that the RNA-cutting enzyme Dicer and its partner BRD4 stabilize human chromosomes points toward a new strategy for cancer therapy.
March 2022. Full story at Cold Spring Harbor Laboratory.
The discovery that the RNA-cutting enzyme Dicer and its partner BRD4 stabilize human chromosomes points toward a new strategy for cancer therapy.
March 2022. Full story at Cold Spring Harbor Laboratory.